Global Cell Culture Market Expected to Register CAGR

0

Dublin, May 26, 2022 (GLOBE NEWSWIRE) — The “Global cell culture market by product (consumables (medium, serum, reagent, vessels), equipment (bioreactor, centrifuge, incubator)), application (vaccines, mAbs, diagnostics, tissue engineering), end user (pharmaceutical, biotechnology, hospital) – Forecast until 2026″ report has been added to from ResearchAndMarkets.com offer.

The global cell culture market is expected to reach USD 41.3 billion by 2026, from USD 22.8 billion in 2021, growing at a CAGR of 12.6% between 2021 and 2026. The growth of this market is mainly driven by growing awareness of the benefits of cell culture. vaccines, growing demand for monoclonal antibodies (mAbs), funding for cellular research, growing preference for single-use technologies, the launch of advanced cell culture products, and the growing focus on personalized medicine. On the other hand, the high cost of cell biology research is holding back the growth of this market.

Consumables segment accounted for the highest growth rate in the cell culture market, by product, during the forecast period

In 2020, the consumables segment accounted for the highest growth rate. Cell culture consumables are segmented into sera, media, reagents; ships; And accessories. The sera, media and reagents segment is expected to account for the largest share of the cell culture consumables markets. The large share of this segment is attributed to the repeat purchase and high volume requirement of sera, media and reagents for various cell culture applications. Thermo Fisher Scientific Inc. (USA), Merck KGaA (Germany), Danaher Corporation (USA), Corning Incorporated (USA), Eppendorf AG (Germany), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Sartorius AG (Germany), Agilent Technologies, Inc. (USA), Getinge AB (Sweden), Becton, Dickinson and Company (USA), Miltenyi Biotec (Germany), HiMedia Laboratories (India ) are among the major players operating in the cell culture market.

Asia-Pacific: the fastest growing region in the cell culture market

The cell culture market is segmented into North America, Europe, Asia-Pacific, Latin America (LATAM), and Middle East and Africa (MEA). The Asia-Pacific market is estimated to register the highest CAGR of 14.0% during the forecast period. Government initiatives for stem cell therapy research, growing geriatric population, growing importance of research in regenerative medicine, increasing number of researchers in Japan, growth of preclinical/clinical research in China, favorable changes in the regulation of Foreign direct investment (FDI) in the pharmaceutical sector in India and the growth of the pharmaceutical and biopharmaceutical sectors in South Korea are the major factors contributing to the growth of the cell culture market in Asia-Pacific.

List of companies featured in the report:

  • Thermo Fisher Scientific Inc. (USA)
  • Merck KGaA (Germany)
  • Danaher Corporation (USA)
  • Corning Incorporated (USA)
  • Eppendorf AG (Germany)
  • FUJIFILM Irvine Scientific, Inc. (Japan)
  • Lonza Group AG (Switzerland)
  • Sartorius AG (Germany)
  • Agilent Technologies, Inc. (USA)
  • Getinge AB (Sweden)
  • Becton, Dickinson and Company (USA)
  • Miltenyi Biotec (Germany)
  • HiMedia Laboratories (India)
  • STEMCELL Technologies Inc. (Canada)
  • Solida Biotech GmbH (Germany)
  • Caisson Laboratories Inc. (USA)
  • PromoCell GmbH (Germany)
  • InvivoGen (USA)
  • Pan-Biotech GmbH (Germany)
  • Cellexus (UK)
  • Filtration products Meissner Inc. (USA)
  • Adolf Kuhner AG (Switzerland)
  • SeraCare Life Sciences Inc. (USA)
  • ANGUS Chemical Company (USA)
  • Biospherix Ltd. (United States)

Market dynamics

Drivers

  • Growing awareness of the benefits of cellular vaccines
  • Growing demand for monoclonal antibodies
  • Funding for cell research
  • Growing preference for single-use technologies
  • Launch of advanced cell culture products
  • Growing focus on personalized medicine

Constraints

  • High cost of cell biology research
  • Limitations in producing high-density cell cultures

Opportunities

  • Growing demand for 3D cell culture
  • Growing risk of pandemics and communicable diseases
  • Emerging economies

Challenges

For more information on this report, visit https://www.researchandmarkets.com/r/5xk9r0


        
Share.

Comments are closed.